Strain B-009 has been isolated from the soil (Tsukuba, Ibaraki Prefecture, Japan) and can convert diethylene glycol to -hydroxyethoxy acetic acid by co-oxidation [1] [2] [3] [4] in the presence of PD which is used as a carbon source for growth. 5, 6) Since PD is completely removed from the culture fluid during cultivation, 6 ) the strain should possess alcohol dehydrogenases (ADHs) specific for each optical isomer. The use of biocatalysts, including enantioselective ADHs, is promising to produce enantiomerically pure chemicals. 7, 8) ADHs can be classified into three major groups: iron-dependent dehydrogenases, short-chain dehydrogenases/reductases (SDRs), and medium-chain dehydrogenases/reductases (MDRs). 9, 10) SDR (EC1.1.1.76) and MDR (EC1.1.1.4) types of 2,3-butanediol dehydrogenases (BD-DHs), which enantioselectively interconvert 2,3-butanediol (BD) and acetoin, have been extensively studied. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Considering that known BD-DHs can also enantioselectively act on other related diols, including PD, we expected prospective PD dehydrogenase (PD-DH) of strain B-009 to act on BD. We intend in this study to purify and characterize an enantioselective PD-DH from strain B-009 and to taxonomically characterize strain B-009 in terms of its phenotypic and phylogenetic properties.
Materials and Methods
Bacterial strain and culture conditions. Strain B-009 was preserved on an agar slant (15 g/L) of PDY medium (5 mL of PD, 0.1 g of yeast extract, 1 g of NaNO 3 , 1.5 g of KH 2 PO 4 , 1.5 g of K 2 HPO 4 , 0.1 g of C. Cultivation for enzyme preparation was done under aerobic conditions in PDY medium at 30 C for 65 h while shaking.
Phenotypic characterization of the bacterial strain. Strain B-009 was cultivated at 30 C for 72-96 h on standard Löwenstein-Jansen medium 28) (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) for taxonomic characterization of mycobacterial strains. Growth was examined at 20 C, 37 C, and 45 C for 7 d. Cell morphology was observed with a scanning electron microscope (3D SEM, Keyence, Osaka, Japan). The effect of antibiotics on growth was examined by depositing a paper disk soaked with 0.1 mL of an antibiotic solution (1 mg/mL) on the medium with subsequent incubation at 30 C for 7 d. Gram staining was tested with a Faver G kit (Nissui Pharmaceutical, Tokyo, Japan), and acid production from carbohydrates was investigated according to the method of Gordon and Smith. 29) Urease activity was tested with an EB-20 plate (Nissui Pharmaceutical), catalase production was confirmed with 3% H 2 O 2 , and citrate utilization was examined with Christensen medium 30) at 30 C for 96 h. Hydrolysis of Tween 80 was tested at 30 C for 96 h on a plate with the following composition: 10 g of bacto-peptone (Becton, Dickinson and Company), 5 g of NaCl, 0.1 g of CaCl 2 , 10 mL of Tween 80, and 15 g of agar per liter. Hydrolysis was distinguished by the formation of an opaque zone surrounding the colonies.
Identification of mycolic acid. Cells grown on PYG medium 31) at 30 C for 72 h were used to extract and identify mycolic acids, according to the method described elsewhere. [32] [33] [34] In brief, packed cells were treated with KOH to release mycolic acid and then methyl esterified. The major mycolic acid methyl esters were recovered by thin-layer chromatography (TLC) and treated with the TMSI-H trimethylsilylating reagent (GL Sciences, Tokyo, Japan). The trimethylsilylated mycolic acid methyl esters were subjected to gas chromatography/mass spectrometry (GC/MS) under the following conditions: instrument, HP5890A (Hewlett-Packard, Palo Alto, CA, USA) combined with a JMS-DX303 (Jeol, Tokyo, Japan); carrier gas, He; column, SBP-1 (0:25 mm Â 10 m; Supelco, Bellefonte, PA, USA); column temperature, 70 Phylogenetic analysis. A phylogenetic analysis of strain B-009 based on 16S rDNA was performed by the neighbor-joining method as previously described. 35) Total DNA of strain B-009, which had been grown in PDY medium at 30 C for 18 h, was purified by using a Wizard genomic DNA purification kit (Promega, Madison, WI, USA). The 16S rDNA was amplified by PCR, using universal primers 9F and 1510R, and subsequently sequenced with an ABI Prizm 3100 DNA sequencer (Applied Biosystems, Foster City, CA, USA). The determined nucleotide sequence (1451 bp) was deposited as AB613819. The phylogenetic relationship for enantioselective ADH found in strain B-009 with related ADHs was also estimated by using the neighborjoining method in the same manner. 35) Enzyme and protein assays. The dehydrogenating activity of R-PD and other alcohols was determined by monitoring the NADH concentration (absorbance at 340 nm), using a V-630BIO spectrophotometer (Jasco, Tokyo, Japan) equipped with a temperature control system. A kinetic analysis was also performed by using this equipment. The standard composition of the basal reaction mixture (950 mL) was 100 mM Tris-HCl buffer at pH 7.5 containing 1 mM NAD þ and 10 mM substrate. The mixture was preincubated at 30 C, and the reaction was initiated by adding 50 mL of the enzyme solution. The reductive reaction was also examined at 30 C by using a basal reaction mixture of 955 mL of 33 mM Søerensen sodium-potassium phosphate buffer (pH 7.0) containing 0.2 mM NADH and 120 mM acetoin. The reaction was started by adding 5 mL of the enzyme solution. The oxidative and reductive activities are reported in units (U), 1 U implying 1 mmol of NADH formed or removed per minute. Proteins were quantified with a BCA protein assay kit (Thermo Fisher Scientific, Rockford, IL, USA). The purity and molecular weight of the proteins were elucidated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and staining with Coomassie Brilliant Blue (CBB). The N-terminal amino acid sequence was determined by blotting the proteins on a Sequi-Blot polyvinylidene difluoride membrane (BioRad, Hercules, CA, USA) and subsequently analyzed with a G1000A protein sequencer (Hewlett-Packard). The molecular weight of the purified enzyme in an active form was estimated by size-exclusion chromatography (SEC), using a Diol-300 column (7:5 Â 30 mm; Nacalai Tesque, Kyoto, Japan) at a flow rate of 0.8 mL/min. The mobile phase was 67 mM Søerensen sodium-potassium phosphate buffer at pH 7.0 containing 20 mM Na 2 SO 4 , enzyme elution being monitored at 280 nm. A gel filtration standard (Bio-Rad) was used as the molecular weight standard protein.
Enzyme purification. Strain B-009 was grown in PDY medium at 30 C for 72 h. The cells recovered by centrifugation from 1.6 L of the culture were suspended in 40 mL of 50 mM Tris-HCl buffer at pH 7.5 supplemented with 1 mM 2-mercaptoethanol (Tris-HCl-M buffer) and then subjected to sonication on ice. The cell debris was removed by centrifugation and subsequently passed through a GF-75 glass filter (Advantec, Tokyo, Japan). The filtrate (the crude enzyme) was loaded into a column (2:5 Â 15 cm) packed with DEAE Sepharose FF (GE Healthcare, Little Chalfont, Buckinghamshire, UK), and the column was washed with Tris-HCl-M buffer. The proteins were eluted at a flow rate of 4 mL/min with a linear gradient of NaCl (0-0.8 M in 80 min) in a mobile phase of Tris-HCl-M buffer. The active fraction was dialyzed at 4 C with Visking12-14k (Serva, Heidelberg, Germany) against TrisHCl-M buffer, before being concentrated to 5 mL by ultrafiltration (10k, Amicon Ultra-15; Millipore, Billerica, MA, USA). The concentrate was passed through a 0.45-mm Ekicrodisc 13 filter (Pall, Port Washington, NY, USA) and then loaded on a Resource Q column (6 mL, GE Healthcare). Chromatography was performed with a linear gradient of NaCl (0-0.5 M in 60 min) in a mobile phase of the Tris-HCl-M buffer at a flow rate of 1.0 mL/min. To the recovered active fraction, (NH 4 ) 2 SO 4 was added to reach 1.2 M. The mixture was passed through a GA55 filter (Advantec) and loaded on a Resource ISO column (1 mL, GE Healthcare). Proteins were eluted from the column with a linear gradient of (NH 4 ) 2 SO 4 (1.2-0.6 M in 60 min) in a mobile phase (TrisHCl-M buffer) at a flow rate of 1.0 mL/min. The active fraction was dialyzed against a 100 mM Tris-HCl buffer at pH 7.5 and 4 C, concentrated to 0.45 mL by ultrafiltration (10k, Vivaspin 500; Sartorius, Göttingen, Germany), and subjected to native-PAGE. To the sample solution, 50 mL of glycerol colored with bromophenol blue was added, and electrophoresis at 25 mA was performed for 80 min with an NPL-520L slab gel (12 wells; Atto, Tokyo, Japan) in combination with GT buffer consisting of 14.4 g/L of glycine and 3.0 g/L of Tris(hydroxylmethyl)aminomethane. Both side edges of the gel were cut off after electrophoresis and stained with CBB to locate a prominent band. The area corresponding to this band was recovered from the unstained gel, and protein was eluted with a model 422 electro-eluter (Bio-Rad) filled with GT buffer. Elution was performed at 10 C for 3 h according to the manual, and the recovered protein was used as the purified enzyme.
Identification of the enzymatic product. An enzymatic reaction mixture (1 mL) containing R-PD was prepared as already described. After reacting at 30 C for 1 h, it was passed through a DSC-18 cartridge (Supelco), and 0.5 mL of the passage was recovered. The enzymatic products in this passage were converted with 2,4-dinitrophenylhydrazine (DNPH) according to the method of Duan et al. 36) with slight modifications. To the recovered passage, 2.5 mL of a DNPH solution (2 mg/mL in 20 wt% of sulfuric acid) was added, and the mixture was incubated at 40 C for 15 min. After cooling, 2.5 mL of hexane was added, vigorously shaken and then centrifuged. The upper phase was recovered, this operation being repeated for the residual lower phase. To the combined hexane extract, 5 mL of 200 mM Søerensen sodium-potassium phosphate buffer at pH 7.0 was added, agitated and centrifuged to recover the hexane phase. The repeatedly recovered hexane phase was dried in a stream of air at 35 C, and the dried material was dissolved in 50 mL of hexane. The derivative was identified by GLC under analytical conditions as follows: column, TC-1 (0:25 mm Â 30 m; GL Sciences); carrier gas, He; temperature program, 100 C for 15 min, a linear gradient at 4 C/min to 250 C, and 250 C for 20 min. The derivative from commercially available hydroxyacetone was prepared as the standard in the same manner and subjected to the GLC analysis.
DNA analysis. The putative ADH gene was identified by a 7-step procedure.
Step 1: Based on the N-terminal amino acid sequence of the purified enzyme, a set of degenerated primers (forward 5 0 -ATG-AAAGCNGCTGTCTA-3 0 , reverse 5 0 -GGTACATCGGCGACCTC-3 0 ) was designed, and PCR amplification of the corresponding DNA fragment (54 bp) was attempted.
Step 2: After amplification, the product was ligated with pCR-TOPO (Invitrogen, San Diego, CA, USA).
Step 3: A portion of the ligated mixture was added to a PCR cocktail together with M13F and M13R plasmid specific primers (Invitrogen). PCR was performed to amplify the N-terminal region which was extended with the pCR-TOPO fragments at both ends.
Step 4: The desired PCR product was purified with a Zymoclean gel DNA recovery kit (Zymo Research, Irvine, CA, USA) after agarose gel electrophoresis, and then sequenced (ABI Prizm 3100 DNA sequencer, Applied Biosystems), using the plasmid-specific primers.
Step 5: A BLAST homology search was carried out based on the determined nucleotide sequence (5 0 -TACTACGGTCCAAACAAAGTC-3 0 ) of the N-terminal region. Putative mycobacterial ADH (MDR type) genes (CP000480:MSMEG5021, CP000511:Mvan0788, CP000656:Mflv0125) were found to possess closely similar sequences in their N-terminal regions. The preserved regions with lower GC content were searched in ORFs adjacent to these putative mycobacterial ADH genes by a ClustalW multiple-alignment analysis in order to design PCR primers to amplify the region, including the gene coding ADH acting on R-PD, from genomic DNA of strain B-009. A forward degenerated primer (5 0 -TCTSGAACTCGATGAA-3 0 ) was designed by referring to ORFs for a hypothetical protein (CP000480:MSMEG5022, CP000511:Mvan0787, CP000656:Mflv0126), and a reverse primer (5 0 -ACCATGATGTCTC-GAA-3 0 ) was designed by referring to ORFs for putative SDR-type ADH (CP000480:MSMEG5020, CP000511:Mvan0789, CP000656: Mflv0124).
Step 6: PCR was performed by using this primer set, and the product (1.7 kbp) was subsequently recovered from the reaction mixture by using an AutoSeq G-50 dye terminator removal kit (GE Healthcare).
Step 7: The PCR product was sequenced by using the above-mentioned four primers, the determined nucleotide sequence being deposited in the database under accession no. AB618205.
Peptide mass fingerprinting (PMF).
A PMF analysis was performed according to the procedure reported by Fernandez et al. 37) to confirm if the prospective ADH gene of strain B-009 coded the enzyme. SDS-PAGE of the purified enzyme yielded a spot of protein which was excised. This protein in the recovered gel tip was digested with trypsin (Promega, Madison, WI, USA), mixed with -cyano-4-hydroxycinnamic acid in 50 vol% of acetonitrile containing 0.1 vol% of trifluoroacetic acid, and subjected to MALDI-TOF mass spectrometry in the positive mode (Microflex LRF 20; Bruker Daltonics, Billerica, MA). Spectra were collected from 300 shots per spectrum over an m=z range of 600-3000 and calibrated by 2-point internal calibration, using the trypsin auto-digestion peaks (m=z 842.5099 and 2211.1046). A peak list was generated by the Flex Analysis 3.0 program (Bruker Daltonics). The MASCOT search program (http://www.matrixscience. com/) was used for to identify proteins based on probability scoring.
Results and Discussion

Phylogenetic and phenotypic characteristics of strain B-009
The phylogenetic tree ( Fig. 1 ) constructed with 16S rDNAs strongly suggested strain B-009 to be a member of the genus Mycobacterium and closely related to M. gilvum (99.5% similarity) which is known to be a rapidly growing and opportunistic species. 38) Nonclinical strains of the genus Mycobacterium are widespread in various environments, [39] [40] [41] and strain B-009 is supposed to be one such member. Mycolic acids were extracted and defined to ensure that the strain belonged to the genus Mycobacterium in terms of its chemotaxonomy. The mycolic acids were detected by using TLC, and a subsequent GC/MS analysis revealed the major mycolic acids to be C58-66 (C39-46 -unit and C22-25 -unit). These mycolic acids are common in rapidly growing mycobacterial strains as short-chained -mycolic acids. 42, 43) The colonies of strain B-009 formed on Löwenstein-Jansen medium were convex, smooth, opaque, and pale yellow. Growth occurred at 25 C, 30 C and 37 C within 7 d, but not at 45 C. We thus confirmed strain B-009 to be a rapidly growing member 44) of the genus Mycobacterium. The cells were Gram-positively stained, and the SEM image (Supplemental Fig. S1 ; see the Biosci. Biotechnol. Biochem. Web site) revealed them to be rod shaped (0.4-0.7 mm in width and 1.7-3.2 mm in length). Both the urease and catalase activities were positive. Tween 80 was hydrolyzed and citrate was utilized. These properties of strain B-009 were the same as those of M. gilvum, 38) but the strain exhibited different carbohydrate utilization and antibiotic resistance as listed in Supplemental Table S1 .
Since the differences were too significant to identify strain B-009 as M. gilvum, it should be temporarily named Mycobacterium sp. B-009. Several ADHs have been isolated and characterized from mycobacterial strains, but the enzymes were not enantioselective. [45] [46] [47] [48] [49] Isolation and properties of enantioselective PD-DH Excessive cultivation of strain B-009 for over 72 h in PYG and PDY media promoted the secretion of a mucous substance that impeded cell recovery by centrifugation and cell disruption by sonication. It is known that various mycobacterial strains secrete highly branched -glucans as capsular polysaccharides. [50] [51] [52] Strain B-009 was assumed to excessively produce such an extracellular polysaccharide from glucose and PD. In consequence, a minimum cultivation time was most suitable for enzyme preparation. As a preliminary experiment for S-PD-or R-PD-specific ADH isolation, ADH activity for each optical isomer in the crude enzyme was measured. Strong NAD þ -dependent ADH activity was detected for R-PD, while its NADP þ -dependent activity was relatively weak. No marked activity was detected for S-PD in the presence of NAD þ or NADP þ . It seems likely that an S-PD-specific ADH would be unstable or not effectively function under the given conditions for its extraction and assay. We focused on the NAD þ -dependent R-PD-DH activity and purified the enzyme responsible for this activity, using the procedure summarized in Table 1 . As the final purification step, native-PAGE was effective for removing the remaining contaminating proteins (Fig. 2a) . The enzyme eluted and recovered from the gel was detected as a single band of 3:9 Â 10 4 by SDS-PAGE (Fig. 2b) . The N-terminal amino acid sequence was determined to be H 2 N-MKAAVYYGPNKVEVADVP. Size-exclusion chromatography revealed the molecular weight of the purified enzyme to be 8:0 Â 10 4 , suggesting that the enzyme was a dimer composed of identical polypeptides. The molecular weight and subunit structure of the enzyme coincided well with those of bacterial ADHs belonging to the MDR family. 53) As denoted in Table 2 , the enzyme could strictly distinguish between R-and S-PD. Besides PD, other diols with neighboring hydroxyl groups served as suitable substrates for the enzyme, the highest activity among these being attained with R,R-BD. In contrast, monohydric alcohols, trihydric alcohols, and diols with distantly arranged hydroxyl groups were less or not affected by the enzyme. Such substrate specificity indicated that the enzyme should be categorized as R,R-BD-DH. This possibility was further confirmed by the higher affinity of the enzyme for R,R-BD; the apparent K m values for R,R-BD and R-PD were 0.34 and 11.5 mM, respectively. In addition, the apparent K m value for NAD þ was estimated to be 0.06 mM, while the reaction would not proceed when NAD þ was replaced with NADP þ , revealing the strict dependence on NAD þ . Detailed characterization of the enzyme was therefore performed by using R,R-BD as a substrate. The enzyme lost its activity under acidic conditions, while alkaline conditions were favorable for its action and stability (Fig. 3a) . It should be noted here that the enzyme was promptly precipitated below pH 5. Such instability under acidic conditions made isoelectric focusing not applicable for the enzyme. The activity was significantly affected by both the pH value and the buffer system used. Tris-HCl buffer (pH 8.5) was suitable for both stability and exerting enzymatic activity, while glycine-NaOH buffer was not suitable for triggering the enzymatic activity (Fig. 3a) . The effects of temperature on the activity and stability of the enzyme are demonstrated in Fig. 3b . The highest initial activity was attained at 85 C, but the enzyme was rapidly denatured at above 50 C. The effects of metal ions and inhibitors are summarized in Supplemental  Table S2 . The enzymatic reaction was inhibited by thiol-modifying reagents (especially 5,5 0 -dithio-bis-(2-nitrobenzoic acid), chelating reagents (EDTA and 2,2 0 -bipyridyl) and metal salts (HgCl 2 , CuCl 2 and ZnSO 4 ), revealing a metal ion requirement and the involvement of thiol groups in exerting the enzymatic activity. A GLC analysis revealed that the enzymatic product from R-PD was hydroxyacetone, indicating that position 2 of the substrate was oxidized. R,R-BD was considered to be oxidized to form acetoin. The reduction of acetoin was attempted by R,R-BD-DH in the presence of NADH as an electron donor to confirm this. The reductive reaction proceeded, and the apparent K m for acetoin was estimated to be 0.06 mM.
Identification of R,R-BD-DH gene
Based on the N-terminal amino acid sequence, an ORF of 1047 bp coding 348 amino acid residues was successfully amplified and sequenced by using the procedure described in the Materials and Methods section. The theoretical molecular weight and isoelectric point of the prospective polypeptide were 36430 and The dehydrogenation activity against R,R-BD was assayed for 30 s in reaction mixtures of the indicated pH values (a, solid line) buffered with 100 mM sodium citrate ( ), sodium-potassium phosphate ( ), Tris-HCl ( ), or glycine-NaOH ( ). R,R-BD-DH solutions in various buffers (20 mM) were incubated for 1 h at 30 C, and then the residual activity was measured in a standard reaction mixture supplemented with R,R-BD (a, broken line). The dehydrogenation activity against R,R-BD was assayed for 30 s at various temperatures (b, solid line). The basal reaction mixture omitting the substrate and containing R,R-BD-DH was incubated at the indicated temperature for 1 h, and the residual activity was then measured by adding R,R-BD (b, broken line). pH 4.9, respectively. The theoretical molecular weight coincided with the subunit molecular weight of R,R-BD-DH isolated from strain B-009. A PMF analysis of R,R-BD-DH was performed to elucidate the ORF encoding it. The highest probability score of 144 (scores higher than 72 were significant) was obtained for the ORF, and the fragments detected are indicated in Fig. 4 . The scores for all other entries in the database were far less than 72. The ORF was thus identified as the R,R-BD-DH gene and designated mbd1 (a gene coding mycobacterial 2,3-BD-DH). We found a putative À10 arrangement, 5 0 -TACAAC-3 0 , 54) upstream of the initiation codon (refer to AB618205). The deduced amino acid sequence of mbd1 (Fig. 4) has a highly conserved NAD(P) þ -binding region together with zinc-binding sites for bacterial MDR. These zinc-binding sites include a typical site with a preference for secondary alcohols. 55) All these facts are in accordance with the substrate specificity of the enzyme ( Table 2 ). As shown in Fig. 4 , mbd1 exhibited close similarity to ORFs in the genome of M. vanbaalenii (CP000511:Mvan0788, 81.8% and 85.1% in respective nucleotide and amino acid sequences), M. gilvum (CP000656:Mflv0125, 80.2% and 82.9% in respective nucleotide and amino acid sequences), and M. semegmatis (CP000480: MSMEG5021, 79.0% and 81.6% in respective nucleotide and amino acid sequences). These ORFs possess characteristic motifs of the MDR type of R,R-BD-DH, as indicated in Fig. 4 . They are therefore supposed to be coding this enzyme. NAD þ -dependent MDR-type R,R-BD-DHs have been confirmed and characterized from Bacillus cereus, 53) Paenibacillus polymyxa, 17) and Saccharomyces cerevisiae.
56) Figure 5 shows the phylogenetic position of Mbd1 among R,R-BD-DHs of these microbes and putative mycobacterial R,R-BD-DHs. Mbd1 formed a distinctive group, together with putative mycobacterial R,R-BD-DHs, revealing their novelty. As described in the Materials and Methods section (Step 5), the putative MDR-type R,R-BD-DH genes of mycobacteria are followed by putative SDR, prospective acetoin reductase, genes (CP000480:MSMEG5020, CP000511: Mvan0789, and CP000656:Mflv0124) without regulatory insertions. We found a similar arrangement downstream of mbd1 (refer to AB618205). Acetoin reductase is a category of SDRs that catalyze the interconversion of S-acetoin and S,S-BD. 57, 58) Genes homologous to mbd1 are presumably widespread and accompanied by S,S-BD-DH (acetoin reductase) genes in the mycobacterial genome. These genes may comprise an operon for the interconversion of BD and acetoin. The presence of R,R-and/or S,S-BD-DH genes has been confirmed in Raoultella terrigena, 57, 59) Klebsiella pneumoniae,
57)
Bacillus cereus, 53, 60) Paenibacillus polymyxa, 17) Pseudomonas putida, 61) and Corynebacterium glutamicum. 58, 62) It is interesting that the tandem arrangement of these two genes to form an operon is not recognized in listed eubacteria. The tandem arrangement of R,Rand S,S-BD-DH genes might be a characteristic feature of mycobacteria, if their putative SDR genes can be confirmed to code S,S-BD-DHs. 
